liposomal quercetin

Liposomal quercetin is a **liposome-encapsulated formulation of quercetin**, a plant-derived small molecule flavonoid and polyphenol, designed to improve quercetin's very poor aqueous solubility and low native oral bioavailability. It is not a single proprietary branded drug but rather a formulation concept used in preclinical and nutraceutical settings. The proposed pharmacology derives from quercetin's antioxidant, anti-inflammatory, and potential anticancer activities, with liposomal delivery intended to enhance absorption, tissue exposure, and cellular uptake. Published work has described quercetin-loaded nano-liposomes with activity in colon cancer cell models and other preclinical settings such as solid tumors and hepatic ischemia-reperfusion injury, including reported effects on apoptosis and reduced epidermal growth factor receptor signaling. There is no clear evidence from the provided context that liposomal quercetin is an approved prescription pharmaceutical product developed by a single sponsor.

Other names

quercetin-loaded liposomesquercetin-loaded nano-liposomesnano-liposomal quercetin